Welcome Guest | Register / Login

Cervical Cancer Market Research Reports

Sort By
Title Published Price
USA & Canada Cervical Cancer Diagnostic Market, Patients by Test Type (Pap Smear, HPV DNA), in North America
By Renub Research
Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. North America Cervical Cancer Screening Market is projected to reach US$ 100 Million by the year 2024. Cervical cancer affe...
Jul 2018 $ 990
Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries & Forecast
By Renub Research
Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. Cervical cancer test market in Asian region is growing and expected to cross over 1,000 million dollars by 2024. Cervical c...
Jun 2018 $ 1290
Europe Cervical Cancer Diagnostics Market & Forecast, By Test Type (Pap smear & HPV DNA) & Countries
By Renub Research
Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 23 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incid...
Jun 2018 $ 1290
Global Cervical Cancer Partnering 2010 to 2017
By Current Partnering
"Delivery of this report will take 1-3 days after purchase." The Global Cervical Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered int...
Nov 2017 $ 1495
The 2018-2023 World Outlook for Cervical Cancer Drugs and Diagnostics
By ICON Group International, Inc.
This study covers the world outlook for cervical cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ...
Apr 2017 $ 995
Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America
By Renub Research
Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most pre...
Jan 2017 $ 1000
Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands)
By Renub Research
Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incid...
Jan 2017 $ 1250
Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)
By Renub Research
Cervical cancer test market in Asian region is growing and expected to cross over Billion dollars by 2020. Despite declining women population, Japan has highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervic...
Jan 2017 $ 1250
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide
By Renub Research
Renub Research report titled ""Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” provides a comprehensive analysis of the current state of this market and likely future evolut...
Apr 2014 $ 1490
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy